Yun and colleagues reported recently that the oxidised form of AA, dehydroascorbate (DHA) rather than AA was responsible for selectively killing glycolysis-driven colorectal cancer cells with BRAF and KRAS mutations [6]. The gene discussed is BRAF; the disease is colorectal cancer.